IVD Medical Holding Limited

SEHK:1931 Rapporto sulle azioni

Cap. di mercato: HK$2.6b

IVD Medical Holding Gestione

Gestione criteri di controllo 4/4

IVD Medical Holding Il CEO è Kuk Sing Ho, nominato in Jun2019, e ha un mandato di 5.5 anni. la retribuzione annua totale è CN¥ 3.70M, composta da 99.8% di stipendio e 0.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 10.8% delle azioni della società, per un valore di HK$ 280.83M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.5 anni e 3.2 anni.

Informazioni chiave

Kuk Sing Ho

Amministratore delegato

CN¥3.7m

Compenso totale

Percentuale dello stipendio del CEO99.8%
Mandato del CEO5.5yrs
Proprietà del CEO10.8%
Durata media del management5.5yrs
Durata media del Consiglio di amministrazione3.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Dec 12
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Oct 14
IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

Sep 27
Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

Aug 17
IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

Jun 07
Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

May 22
These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 25
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 03
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

Mar 30
IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Mar 20
IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Feb 08
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Oct 22
Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

Oct 01
IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

Aug 22
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 05
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Mar 22
IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Feb 16
Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Oct 16
Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Sep 28
Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

May 16
IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

Apr 14
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 23
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Mar 16
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

Jul 30
IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

May 04
These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

Apr 20
There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Mar 05
IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 15
Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

Jan 31
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Jan 16
A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

Jan 01
Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Dec 17
How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

Dec 02
Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Nov 19
IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Kuk Sing Ho rispetto agli utili di IVD Medical Holding?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

CN¥260m

Mar 31 2024n/an/a

CN¥249m

Dec 31 2023CN¥4mCN¥4m

CN¥238m

Sep 30 2023n/an/a

CN¥235m

Jun 30 2023n/an/a

CN¥232m

Mar 31 2023n/an/a

CN¥221m

Dec 31 2022CN¥5mCN¥4m

CN¥210m

Sep 30 2022n/an/a

CN¥193m

Jun 30 2022n/an/a

CN¥177m

Mar 31 2022n/an/a

CN¥176m

Dec 31 2021CN¥4mCN¥4m

CN¥175m

Compensazione vs Mercato: La retribuzione totale di Kuk Sing ($USD 507.12K ) è circa la media per le aziende di dimensioni simili nel mercato Hong Kong ($USD 393.64K ).

Compensazione vs guadagni: La retribuzione di Kuk Sing è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Kuk Sing Ho (64 yo)

5.5yrs

Mandato

CN¥3,700,000

Compensazione

Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Kuk Sing Ho
Chairman & CEO5.5yrsCN¥3.70m10.8%
HK$ 280.8m
Xianya Lin
GM & Executive Director5.5yrsCN¥2.16m6.93%
HK$ 180.3m
Kim Fai Law
CFO, Company Secretary & Executive Directorless than a yearNessun datoNessun dato
Siu Kei Ken Chan
Executive Directorless than a yearNessun datoNessun dato
Bo Yang
Financial Controller8.8yrsNessun datoNessun dato

5.5yrs

Durata media

47yo

Età media

Gestione esperta: Il team dirigenziale di 1931 è esperto e expertise (durata media dell'incarico 5.5 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Kuk Sing Ho
Chairman & CEO8.6yrsCN¥3.70m10.8%
HK$ 280.8m
Xianya Lin
GM & Executive Director8.9yrsCN¥2.16m6.93%
HK$ 180.3m
Kim Fai Law
CFO, Company Secretary & Executive Directorless than a yearNessun datoNessun dato
Siu Kei Ken Chan
Executive Directorless than a yearNessun datoNessun dato
Sze Lok Wong
Independent Non-Executive Directorless than a yearNessun datoNessun dato
Renqian Zhong
Independent Non-Executive Director5.5yrsCN¥120.00kNessun dato
Ka Sing Leung
Independent Non-Executive Director5.5yrsCN¥120.00kNessun dato
Haiyun Yao
Non-Executive Director3.2yrsNessun datoNessun dato
Fei Liu
Non-executive Directorless than a yearNessun datoNessun dato

3.2yrs

Durata media

51yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1931 sono considerati esperti (durata media dell'incarico 3.2 anni).

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2024/12/21 11:53
Prezzo dell'azione a fine giornata2024/12/20 00:00
Guadagni2024/06/30
Guadagni annuali2023/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* esempio per i titoli statunitensi, per quelli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più , cliccate qui.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su .

Fonti analitiche

IVD Medical Holding Limited è coperta da 1 analisti. 0 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Yue-Kwong LuiJefferies LLC